The DOI matches its Crossref record; 54 of the 54 references it cites were found in a registry or an index.
Outcomes of patients with end-stage kidney disease hospitalized with COVID-19
Open accessAbstract
Given the high risk of infection-related mortality, patients with end-stage kidney disease (ESKD) may be at increased risk with COVID-19. To assess this, we compared outcomes of patients with and without ESKD, hospitalized with COVID-19. This was a retrospective study of patients admitted with COVID-19 from 13 New York hospitals from March 1, 2020, to April 27, 2020, and followed through May 27, 2020. We measured primary outcome (in-hospital death), and secondary outcomes (mechanical ventilation and length of stay). Of 10,482 patients with COVID-19, 419 had ESKD. Patients with ESKD were older, had a greater percentage self-identified as Black, and more comorbid conditions. Patients with ESKD had a higher rate of in-hospital death than those without (31.7% vs 25.4%, odds ratio 1.38, 95% confidence interval 1.12 - 1.70). This increase rate remained after adjusting for demographic and comorbid conditions (adjusted odds ratio 1.37, 1.09 - 1.73). The odds of length of stay of seven or more days was higher in the group with compared to the group without ESKD in both the crude and adjusted analysis (1.62, 1.27 - 2.06; vs 1.57, 1.22 - 2.02, respectively). There was no difference in the odds of mechanical ventilation between the groups. Independent risk factors for in-hospital death for patients with ESKD were increased age, being on a ventilator, lymphopenia, blood urea nitrogen and serum ferritin. Black race was associated with a lower risk of death. Thus, among patients hospitalized with COVID-19, those with ESKD had a higher rate of in-hospital death compared to those without ESKD.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Multiple Imputation for Nonresponse in Surveys
Rubin, D. B. (1987) · Wiley Series in Probability and Statistics · doi:10.1002/9780470316696 · Cited by 20,701
mice: Multivariate Imputation by Chained Equations in R
Buuren, S. V., & Groothuis-Oudshoorn, K. (2011) · Journal of Statistical Software · doi:10.18637/jss.v045.i03 · Cited by 13,870
Dexamethasone in Hospitalized Patients with Covid-19
The RECOVERY Collaborative Group (2021) · New England Journal of Medicine · doi:10.1056/nejmoa2021436 · Cited by 11,477
Richardson, S., Hirsch, J. S., Narasimhan, M., Crawford, J. M., McGinn, T., Davidson, K. W., and the Northwell COVID-19 Research Consortium, Barnaby, D. P., Becker, L. B., Chelico, J. D., et al. (2020) · JAMA · doi:10.1001/jama.2020.6775 · Cited by 9,254
Self-citationCollaborative, T. O., Williamson, E., Walker, A. J., Bhaskaran, K., Bacon, S., Bates, C., Morton, C. E., Curtis, H. J., Mehrkar, A., Evans, D., et al. (2020) · doi:10.1101/2020.05.06.20092999 · Cited by 6,674 · cited 4×
“In a recent paper from the United Kingdom, the OpenSAFELY Collaborative also found a protective effect of HTN.(10) In their post hoc analysis, the authors found a significant interaction between HTN and age, whereby HTN was associated with lower mortality only among those aged $70 years.”
InfluentialFactors associated with COVID-19-related death using OpenSAFELY
Williamson, E. J., Walker, A. J., Bhaskaran, K., Bacon, S., Bates, C., Morton, C. E., Curtis, H. J., Mehrkar, A., Evans, D., Inglesby, P., et al. (2020) · Nature · doi:10.1038/s41586-020-2521-4 · Cited by 6,674
(2010) · University of Twente Research Information · Cited by 6,037
Benchimol, E. I., Smeeth, L., Guttmann, A., Harron, K., Moher, D., Petersen, I., Sørensen, H. T., von Elm, E., Langan, S. M., & RECORD Working Committee (2015) · PLOS Medicine · doi:10.1371/journal.pmed.1001885 · Cited by 5,749
Docherty, A. B., Harrison, E. M., Green, C. A., Hardwick, H. E., Pius, R., Norman, L., Holden, K. A., Read, J. M., Dondelinger, F., Carson, G., et al. (2020) · BMJ · doi:10.1136/bmj.m1985 · Cited by 3,481 · cited 1×
“and carry significant comorbid conditions, such as diabetes mellitus (DM), cardiac disease, and obesity, which are now considered risk factors for severe COVID-19 disease.(9,10) The ESKD population has higher annual mortality rates compared with the general population, even after adjustment for age, race, and DM.”
Kidney disease is associated with in-hospital death of patients with COVID-19
Cheng, Y., Luo, R., Wang, K., Zhang, M., Wang, Z., Dong, L., Li, J., Yao, Y., Ge, S., & Xu, G. (2020) · Kidney International · doi:10.1016/j.kint.2020.03.005 · Cited by 2,941
Compassionate Use of Remdesivir for Patients with Severe Covid-19
Grein, J., Ohmagari, N., Shin, D., Diaz, G., Asperges, E., Castagna, A., Feldt, T., Green, G., Green, M. L., Lescure, F.-X., et al. (2020) · New England Journal of Medicine · doi:10.1056/nejmoa2007016 · Cited by 2,737
Clinical Characteristics of Covid-19 in New York City
Goyal, P., Choi, J. J., Pinheiro, L. C., Schenck, E. J., Chen, R., Jabri, A., Satlin, M. J., Campion, T. R., Nahid, M., Ringel, J. B., et al. (2020) · New England Journal of Medicine · doi:10.1056/nejmc2010419 · Cited by 2,234
Renin-angiotensin-aldosterone system inhibitors in patients with Covid-19
Vaduganathan, M., Vardeny, O., Michel, T., McMurray, J. J. V., Pfeffer, M. A., & Solomon, S. D. (2020) · New England Journal of Medicine · doi:10.1056/nejmsr2005760 · Cited by 2,101
Simonnet, A., Chetboun, M., Poissy, J., Raverdy, V., Noulette, J., Duhamel, A., Labreuche, J., Mathieu, D., Pattou, F., Jourdain, M., et al. (2020) · Obesity · doi:10.1002/oby.22831 · Cited by 2,079
Potential Effects of Coronaviruses on the Cardiovascular System: A Review
Madjid, M., Safavi-Naeini, P., Solomon, S. D., & Vardeny, O. (2020) · JAMA Cardiology · doi:10.1001/jamacardio.2020.1286 · Cited by 1,793
Acute kidney injury in patients hospitalized with COVID-19
Hirsch, J. S., Ng, J. H., Ross, D. W., Sharma, P., Shah, H. H., Barnett, R. L., Hazzan, A. D., Fishbane, S., Jhaveri, K. D., Abate, M., et al. (2020) · Kidney International · doi:10.1016/j.kint.2020.05.006 · Cited by 1,523
Self-citationObesity in Patients Younger Than 60 Years Is a Risk Factor for COVID-19 Hospital Admission
Lighter, J., Phillips, M., Hochman, S., Sterling, S., Johnson, D., Francois, F., & Stachel, A. (2020) · Clinical Infectious Diseases · doi:10.1093/cid/ciaa415 · Cited by 1,225
Aspects of Immune Dysfunction in End-stage Renal Disease
Kato, S., Chmielewski, M., Honda, H., Pecoits-Filho, R., Matsuo, S., Yuzawa, Y., Tranaeus, A., Stenvinkel, P., & Lindholm, B. (2008) · Clinical Journal of the American Society of Nephrology · doi:10.2215/cjn.00950208 · Cited by 1,087
Multiple Imputation for Nonresponse in Surveys
Campion, W. M., & Rubin, D. B. (1989) · Journal of Marketing Research · doi:10.2307/3172772 · Cited by 764
Sarnak, M. J. (2000) · Kidney International · doi:10.1046/j.1523-1755.2000.00337.x · Cited by 723
Association of inflammatory markers with the severity of COVID-19: A meta-analysis
Zeng, F., Huang, Y., Guo, Y., Yin, M., Chen, X., Xiao, L., & Deng, G. (2020) · International Journal of Infectious Diseases · doi:10.1016/j.ijid.2020.05.055 · Cited by 669
Ghinai, I., McPherson, T. D., Hunter, J. C., Kirking, H. L., Christiansen, D., Joshi, K., Rubin, R., Morales-Estrada, S., Black, S. R., Pacilli, M., et al. (2020) · The Lancet · doi:10.1016/s0140-6736(20)30607-3 · Cited by 577
Bradbury, B. D., Fissell, R. B., Albert, J. M., Anthony, M. S., Critchlow, C. W., Pisoni, R. L., Port, F. K., & Gillespie, B. W. (2007) · Clinical Journal of the American Society of Nephrology · doi:10.2215/cjn.01170905 · Cited by 492
COVID-19: Pathogenesis, cytokine storm and therapeutic potential of interferons
Nile, S. H., Nile, A., Qiu, J., Li, L., Jia, X., & Kai, G. (2020) · Cytokine & Growth Factor Reviews · doi:10.1016/j.cytogfr.2020.05.002 · Cited by 440
Racial and Ethnic Disparities in Population-Level Covid-19 Mortality
Gross, C. P., Essien, U. R., Pasha, S., Gross, J. R., Wang, S.-Y., & Nunez-Smith, M. (2020) · Journal of General Internal Medicine · doi:10.1007/s11606-020-06081-w · Cited by 410
COVID-19–Associated Kidney Injury: A Case Series of Kidney Biopsy Findings
Sharma, P., Uppal, N. N., Wanchoo, R., Shah, H. H., Yang, Y., Parikh, R., Khanin, Y., Madireddy, V., Larsen, C. P., Jhaveri, K. D., et al. (2020) · Journal of the American Society of Nephrology · doi:10.1681/asn.2020050699 · Cited by 367
Self-citationPresentation and Outcomes of Patients with ESKD and COVID-19
Valeri, A. M., Robbins-Juarez, S. Y., Stevens, J. S., Ahn, W., Rao, M. K., Radhakrishnan, J., Gharavi, A. G., Mohan, S., & Husain, S. A. (2020) · Journal of the American Society of Nephrology · doi:10.1681/asn.2020040470 · Cited by 359
COVID-19: clinical course and outcomes of 36 hemodialysis patients in Spain
Goicoechea, M., Sánchez Cámara, L. A., Macías, N., Muñoz de Morales, A., Rojas, Á. G., Bascuñana, A., Arroyo, D., Vega, A., Abad, S., Verde, E., et al. (2020) · Kidney International · doi:10.1016/j.kint.2020.04.031 · Cited by 338
Xiong, F., Tang, H., Liu, L., Tu, C., Tian, J.-B., Lei, C.-T., Liu, J., Dong, J.-W., Chen, W.-L., Wang, X.-H., et al. (2020) · Journal of the American Society of Nephrology · doi:10.1681/asn.2020030354 · Cited by 295
Risk Factors for 30-Day Hospital Readmission in Patients ≥65 Years of Age
Silverstein, M. D., Qin, H., Mercer, S. Q., Fong, J., & Haydar, Z. (2008) · Baylor University Medical Center Proceedings · doi:10.1080/08998280.2008.11928429 · Cited by 251
Alberici, F., Delbarba, E., Manenti, C., Econimo, L., Valerio, F., Pola, A., Maffei, C., Possenti, S., Lucca, B., Cortinovis, R., et al. (2020) · Kidney International · doi:10.1016/j.kint.2020.04.030 · Cited by 248
Predictors of mortality in hemodialysis patients.
Goldwasser, P., Mittman, N., Antignani, A., Burrell, D., Michel, M. A., Collier, J., & Avram, M. M. (1993) · Journal of the American Society of Nephrology · doi:10.1681/asn.v391613 · Cited by 247
Association of Race and Age With Survival Among Patients Undergoing Dialysis
Kucirka, L. M., Grams, M. E., Lessler, J., Hall, E. C., James, N., Massie, A. B., Montgomery, R. A., & Segev, D. L. (2011) · JAMA · doi:10.1001/jama.2011.1127 · Cited by 246
Epidemiology of COVID-19 in an Urban Dialysis Center
Corbett, R. W., Blakey, S., Nitsch, D., Loucaidou, M., McLean, A., Duncan, N., Ashby, D. R., & for the West London Renal and Transplant Centre (2020) · Journal of the American Society of Nephrology · doi:10.1681/asn.2020040534 · Cited by 227
The role of the immune system in kidney disease
Tecklenborg, J., Clayton, D., Siebert, S., & Coley, S. M. (2018) · Clinical and Experimental Immunology · doi:10.1111/cei.13119 · Cited by 217
Causes of death in dialysis patients
Bloembergen, W. E., Port, F. K., Mauger, E. A., et al. (1994) · Journal of the American Society of Nephrology · doi:10.1681/asn.v551231 · Cited by 151
Risk factors for death in 1859 subjects with COVID-19
Chen, L., Yu, J., He, W., Chen, L., Yuan, G., Dong, F., Chen, W., Cao, Y., Yang, J., Cai, L., et al. (2020) · Leukemia · doi:10.1038/s41375-020-0911-0 · Cited by 134
ACE2 alterations in kidney disease
Soler, M. J., Wysocki, J. A., & BATLLE, D. C. (2013) · Nephrology Dialysis Transplantation · doi:10.1093/ndt/gft320 · Cited by 128
Naylor, K. L., Kim, S. J., McArthur, E., Garg, A. X., McCallum, M. K., & Knoll, G. A. (2019) · American Journal of Kidney Diseases · doi:10.1053/j.ajkd.2018.12.011 · Cited by 123
Racial differences in survival of patients on dialysis
Pei, Y., Greenwood, C. M. T., Chery, A. L., & Wu, G. G. (2000) · Kidney International · doi:10.1046/j.1523-1755.2000.00285.x · Cited by 105
Devran, Ö., Karakurt, Z., Adıgüzel, N., Güngör, G., Moçin, Ö. Y., Balcı, M. K., Celik, E., Saltürk, C., Takır, H. B., Kargın, F., et al. (2012) · Multidisciplinary Respiratory Medicine · doi:10.1186/2049-6958-7-47 · Cited by 88
Langefeld, C. D., Divers, J., Pajewski, N. M., Hawfield, A. T., Reboussin, D. M., Bild, D. E., Kaysen, G. A., Kimmel, P. L., Raj, D. S., Ricardo, A. C., et al. (2014) · Kidney International · doi:10.1038/ki.2014.254 · Cited by 82
Karaboyas, A., Morgenstern, H., Pisoni, R. L., Zee, J., Vanholder, R. C., Jacobson, S. H., Inaba, M., Loram, L. C., Port, F. K., & Robinson, B. M. (2018) · Nephrology Dialysis Transplantation · doi:10.1093/ndt/gfy190 · Cited by 80
Hsu, W., Galm, B. P., Schrank, G. M., Hsu, T., Lee, S.-H., Park, J. Y., & Lee, C. (2019) · Hypertension · doi:10.1161/hypertensionaha.119.13197 · Cited by 73
Infectious Disease Risk in Dialysis Patients: A Transdisciplinary Approach
Lamarche, C., Iliuta, I.-A., & Kitzler, T. M. (2019) · Canadian Journal of Kidney Health and Disease · doi:10.1177/2054358119839080 · Cited by 68
Angiotensin-converting enzyme 2 activity in patients with chronic kidney disease
Roberts, M. A., Velkoska, E., Ierino, F. L., & Burrell, L. M. (2013) · Nephrology Dialysis Transplantation · doi:10.1093/ndt/gft038 · Cited by 64
Risk Factors for Mortality in Hemodialysis Patients: Two-Year Follow-Up Study
Faria, M., Ribeiro, S., Costa, E. M., Mendonça, D. M., Teixeira, L., Rocha‐Pereira, P., Fernandes, J. C., Nascimento, H., Kohlová, M., Reis, F., et al. (2013) · Disease Markers · doi:10.1155/2013/518945 · Cited by 60
Price, D. A., & Owen, W. F. (1997) · Advances in Renal Replacement Therapy · doi:10.1016/s1073-4449(97)70011-6 · Cited by 54
Rate of ESRD Exceeds Mortality among African Americans with Hypertensive Nephrosclerosis
Alves, T. P., Wang, X., Wright, J. T., Appel, L. J., Greene, T., Norris, K. C., & Lewis, J. (2010) · Journal of the American Society of Nephrology · doi:10.1681/asn.2009060654 · Cited by 52
Bick, A. G., Akwo, E. A., Robinson‐Cohen, C., Lee, K. M., Lynch, J. A., Assimes, T. L., DuVall, S. L., Edwards, T. L., Fang, H., Freiberg, S. M., et al. (2019) · Circulation · doi:10.1161/circulationaha.118.036589 · Cited by 52
Chen, T. K., Appel, L. J., Grams, M. E., Tin, A., Choi, M. J., Lipkowitz, M. S., Winkler, C. A., & Estrella, M. M. (2017) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/atvbaha.117.309384 · Cited by 50
Comorbidity Burden at Dialysis Initiation and Mortality: A Cohort Study
Gomez, A. T., KIBERD, B. A., Royston, J. P., Alfaadhel, T., Soroka, S., Hemmelgarn, B. R., & Tennankore, K. (2015) · Canadian Journal of Kidney Health and Disease · doi:10.1186/s40697-015-0068-3 · Cited by 45
Excess Deaths Attributable to Influenza-Like Illness in the ESRD Population
Gilbertson, D. T., Rothman, K. J., Chertow, G. M., Bradbury, B. D., Brookhart, M. A., Liu, J., Winkelmayer, W. C., Stürmer, T., Monda, K. L., Herzog, C. A., et al. (2019) · Journal of the American Society of Nephrology · doi:10.1681/asn.2018060581 · Cited by 33
Could ferritin help the screening for COVID-19 in hemodialysis patients?
Bataille, S., Pedinielli, N., & Bergounioux, J.-P. (2020) · Kidney International · doi:10.1016/j.kint.2020.04.017 · Cited by 33
Cited by
Risk factors for severe and critically ill COVID‐19 patients: A review
Gao, Y., Ding, M., Dong, X., Zhang, J., Kursat Azkur, A., Azkur, D., Gan, H., Sun, Y., Fu, W., Li, W., et al. (2021) · Allergy · doi:10.1111/all.14657 · Cited by 1,402
COVID-19 and Solid Organ Transplantation: A Review Article
Azzi, Y., Bartash, R., Scalea, J., Loarte-Campos, P., & Akalin, E. (2021) · Transplantation · doi:10.1097/tp.0000000000003523 · Cited by 301
Gates, M., Pillay, J., Wingert, A., Guitard, S., Rahman, S., Zakher, B., Gates, A., & Hartling, L. (2021) · doi:10.1101/2021.04.23.21256014 · Cited by 5
Metadata
- Authors
- Ng, J. H., Hirsch, J. S., Wanchoo, R., Sachdeva, M., Sakhiya, V., Hong, S., Jhaveri, K. D., Fishbane, S., Abate, M., Andrade, H. P., Barnett, R. L., Bellucci, A., Bhaskaran, M. C., Corona, A. G., Flores Chang, B. S., Finger, M., Fishbane, S., Gitman, M., Halinski, C., Hasan, S., Hazzan, A. D., Hong, S., Khanin, Y., Kuan, A., Madireddy, V., Malieckal, D., Muzib, A., Nair, G., Ng, J. H., Parikh, R., Ross, D. W., Sakhiya, V., Sachdeva, M., Schwarz, R., Shah, H. H., Sharma, P., Singhal, P. C., Uppal, N. N., Wanchoo, R., Hirsch, J. S., Jhaveri, K. D., & Nair, V. V.
- Venue
- Kidney International
- Publisher
- Elsevier BV
- Published
- 2020-12
- Volume
- 98
- Issue
- 6
- Pages
- 1530-1539
- ISSN
- 0085-2538 (ISSN-L)
- OpenAlex
- W3048702451
- Cited by
- 295
- References
- 54
- FWCI
- 7.39
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.